Cite
MLA Citation
Catherine Angwin et al.. “TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol.” BMJ open, vol. 10, no. 12, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127569065.0x00004b